S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

Cameco (NYSE:CCJ) Price Target Raised to C$35.00

Tuesday, October 12, 2021 | MarketBeat

Cameco (NYSE:CCJ) (TSE:CCO) had its price target upped by equities research analysts at Scotiabank from C$27.00 to C$35.00 in a research report issued to clients and investors on Tuesday, The Fly reports. The firm presently has an "outperform" rating on the basic materials company's stock.

CCJ has been the subject of several other research reports. Canaccord Genuity raised their price target on Cameco from C$27.00 to C$34.00 and gave the company a "buy" rating in a report on Thursday, September 23rd. Zacks Investment Research upgraded shares of Cameco from a "strong sell" rating to a "hold" rating in a research report on Thursday, September 16th. TD Securities upgraded shares of Cameco from a "hold" rating to a "buy" rating and set a C$35.00 price objective for the company in a research report on Tuesday, September 28th. Royal Bank of Canada upgraded shares of Cameco from an "underperform" rating to a "sector perform" rating in a research report on Thursday, September 2nd. Finally, Raymond James lifted their price target on Cameco from C$29.00 to C$34.00 and gave the stock an "outperform" rating in a research report on Friday, September 17th. Four analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, Cameco has a consensus rating of "Buy" and an average price target of $28.43.

NYSE CCJ traded up $1.50 during trading hours on Tuesday, reaching $23.03. The company's stock had a trading volume of 448,202 shares, compared to its average volume of 5,918,231. Cameco has a 1 year low of $9.01 and a 1 year high of $26.57. The company has a quick ratio of 5.98, a current ratio of 7.94 and a debt-to-equity ratio of 0.20. The company has a market capitalization of $9.16 billion, a price-to-earnings ratio of -578.50 and a beta of 1.03. The firm's 50-day moving average price is $19.90 and its 200-day moving average price is $18.98.

Cameco (NYSE:CCJ) (TSE:CCO) last issued its earnings results on Tuesday, July 27th. The basic materials company reported ($0.10) earnings per share for the quarter, missing the Zacks' consensus estimate of $0.02 by ($0.12). The company had revenue of $292.25 million for the quarter. Cameco had a negative return on equity of 1.97% and a negative net margin of 1.50%. Equities research analysts anticipate that Cameco will post -0.14 EPS for the current fiscal year.

Several hedge funds and other institutional investors have recently bought and sold shares of CCJ. FMR LLC raised its stake in shares of Cameco by 45,417.1% during the first quarter. FMR LLC now owns 98,317 shares of the basic materials company's stock valued at $1,159,000 after acquiring an additional 98,101 shares in the last quarter. First Trust Advisors LP bought a new stake in Cameco during the 1st quarter valued at $446,000. Amundi Pioneer Asset Management Inc. lifted its holdings in shares of Cameco by 16.1% in the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 185,601 shares of the basic materials company's stock worth $2,189,000 after buying an additional 25,793 shares during the period. BlackRock Inc. grew its position in shares of Cameco by 407.3% during the 1st quarter. BlackRock Inc. now owns 472,234 shares of the basic materials company's stock worth $7,844,000 after buying an additional 379,148 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Cameco by 17.4% during the first quarter. JPMorgan Chase & Co. now owns 1,500,895 shares of the basic materials company's stock valued at $24,930,000 after buying an additional 222,936 shares during the period. Hedge funds and other institutional investors own 60.11% of the company's stock.

Cameco Company Profile

Cameco Corp. engages in the provision of uranium. The company operates through the following segments: Uranium and Fuel Services. The Uranium segment involves the exploration for, mining, milling, purchase and sale of uranium concentrate. The Fuel Services segment involves the refining, conversion and fabrication of uranium concentrate and the purchase and sale of conversion services.

Recommended Story: What are momentum indicators and what do they show?

The Fly logo

Analyst Recommendations for Cameco (NYSE:CCJ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in Cameco right now?

Before you consider Cameco, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.

While Cameco currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.